参考文献/References:
[1] Lynch SV,Pedersen O.The human intestinal microbiome in health and disease[J].New Engl J Med,2016,375(24):2369-2379.
[2] Thomas S,Izard J,Walsh E,et al.The host microbiome regulates and maintains human health:a primer and perspective for non-microbiologists[J].Cancer Res,2017,77(8):1783-1812.
[3] 郭艳杰.妇幼感染微生态[M].沈阳:辽宁科学技术出版社,2015:8-13.
[4] 郭慧玲,邵玉宇,孟和毕力格,等.肠道菌群与疾病关系的研究进展[J].微生物学通报,2015,42(2):40-410.
[5] Schirbel A,Kessler S,Rieder F,et al.Pro-angiogenic activity of TLRs and NLRs:a novel link between gut microbiota and intestinal angiogenesis[J].Gastroenterology,2013,144(3):613-623.
[6] Zhang YJ,Li S,Gan RY,et al.Impacts of gut bacteria on human health and diseases[J].Int J Mol Sci,2015,16(4):7493-7519.
[7] Liu R,Hong J,Xu X,et al.Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention[J].Nat Med,2017,23(7):859-868.
[8] Franks PW,McCarthy MI.Exposing the exposures responsible for type 2 diabetes and obesity[J].Science,2016,354(6308):69-73.
[9] Marchesi JR,Adams DH,Fava F,et al.The gut microbiota and host health:a new clinical frontier[J].Gut,2016,65(2):330-339.
[10] Diamanti-Kandarakis E,Dunaif A.Insulin resistance and the polycystic ovary syndrome revisited:an update on mechanisms and implications[J].Endocr Rev,2012,33(6):981-1030.
[11] Rosenfield RL,Ehrmann DA.The pathogenesis of polycystic ovary syndrome(PCOS):the hypothesis of PCOS as functional ovarian hyperandrogenism revisited[J].Endocr Rev,2016,37(5):467-520.
[12] Randeva HS,Tan BK,Weickert MO,et al.Cardiometabolic aspects of the polycystic ovary syndrome[J].Endocr Rev,2012,33(5):812-841.
[13] Dumesic DA,Oberfield SE,Stener-Victorin E,et al.Scientific statement on the diagnostic criteria,epidemiology,pathophysiology,and molecular genetics of polycystic ovary syndrome[J].Endocr Rev,2015,36(5):487-525.
[14] Tremellen K,Pearce K.Dysbiosis of gut microbiota(DOGMA):a novel theory for the development of polycystic ovarian syndrome[J].Med Hypotheses,2012,79(1):104-112.
[15] Marciniak A,Nawrocka RJ,Brodowska A,et al.Cardiovascular system diseases in patients with polycystic ovary syndrome:the role of inflammation process in this pathology and possibility of early diagnosis and prevention[J].Ann Agric Environ Med,2016,23(4):537-541.
[16] Ebejer K,Calleja-Agius J.The role of cytokines in polycystic ovarian syndrome[J].Gynecol Endocrinol,2013,29(6):536-540.
[17] Gonzalez F,Kirwan JP,Rote NS,et al.Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome[J].Am J Obstet Gynecol,2014,211(6):635 e1-e7.
[18] Saad MJ,Santos A,Prada PO.Linking gut microbiota and inflammation to obesity and insulin resistance[J].Physiology(Bethesda),2016,31(4):283-293.
[19] Perry RJ,Peng L,Barry NA,et al.Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome[J].Nature,2016,534(7606):213-217.
[20] Herrema H,RG IJ,Nieuwdorp M.Emerging role of intestinal microbiota and microbial metabolites in metabolic control[J].Diabetologia,2017,60(4):613- 617.
[21] Mollica MP,Mattace Raso G,Cavaliere G,et al.Butyrate regulates liver mitochondrial function,efficiency,and dynamics in insulin-resistant obese mice[J].Diabetes,2017,66(5):1405-1418.
[22] Fujisaka S,Ussar S,Clish C,et al.Antibiotic effects on gut microbiota and metabolism are host dependent[J].J Clin Invest,2016,126(12):4430-4443.
[23] Cani PD,Amar J,IgIesias MA,et al.Metabolic endotoxemia initiates obesity and insulin resistance[J].Diabetes,2007,56(7):1761-172.
[24] Cani PD,Neyrinck AM,Fava F,et al.Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia[J].Diabetologia, 2007,50(1):2374-2383.
[25] Cani PD,Posemiers S,Van de Wiele T,et al.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability [J].Gut,2009, 58(8):1091-103.
[26] Kelley ST,Skarra DV,Rivera AJ,et al.The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome[J].PLoS One,2016,11(1):e0146509.
[27] Guo Y,Qi Y,Yang X,et al.Association between polycystic ovary syndrome and gut microbiota[J].PLoS One,2016,11(4):e0153196.
[28] Liu R,Zhang C,Shi Y,et al.Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome[J].Front Microbiol,2017,8:324.
[29] 夏桂成.夏桂成实用中医妇科学[M].北京:中国中医药出版社,2017:241-252.
[30] 虞晓含,朱燕波,王 琦,等.体重指数与中医体质类型的对应分析 [J].中医杂志,2015,56(2):105.
[31] 张秀美.湿与肥胖相关的初步研究[J].天津中医药,2014,31(1):59.
[32] 方群英,吴丽敏,孙秀英,等.多囊卵巢综合征不孕患者中医证候分布规律研究[J].时珍国医国药,2018,29(12):3067-3070.
[33] 岳瑶函,赵嘉晶,汪颖珏.多囊卵巢综合征不同中医证型与糖脂代谢水平及性激素水平差异性分析[J].四川中医,2018,36(1):78-81.
[34] 常 惠,张多加, 沈文娟,等.基于中医辨证分型的多囊卵巢综合征分子生物学特点[J].中国中西医结合杂志,2018,38(11):1398-1401.
[35] 张 晗,侯丽辉.多囊卵巢综合征中医病因病机现代研究[J].辽宁中医药大学学报,2011,13(2):40-42.
[36] 陈 旭.从“肾脾两虚,痰瘀壅络”论多囊卵巢综合征病机[J].中国中医基础医学杂志,2016,22(2):267.
[37] 王晓鹏,陈腾飞,卢幼然,等.刘清泉教授“调肝理脾、活血化瘀”治疗多囊卵巢综合征验案举隅[J].世界中医药,2018,13(10):2381-2383.
[38] 李利娜.加用健脾通络调冲方对多囊卵巢综合征患者性激素及子宫内膜容受性的影响[J].广西中医药大学学报,2018,21(4):35-37.
[39] 黄晨曦,夏宛廷,李宛静,等.曾倩教授辨治多囊卵巢综合征经验撷要[J].世界最新医学信息文摘,2018,18(92):256-257.
相似文献/References:
[1]孙双喜,白小欣.从中医生理病理角度谈对脑肠轴的认识[J].陕西中医,2017,(06):787.
[2]赵智宏,徐 杰.从中医脏腑八纲辨证理论探讨胃食管反流病的病机及治疗方法[J].陕西中医,2019,(4):515.
ZHAO Zhihong,XU Jie..Discussion on the pathogenesis and treatment of gastroesophageal reflux disease from the dialectical theory of the eight principles of the internal organs of traditional Chinese medicine[J].,2019,(3):515.
[3]俞 慧,杨 挺△,黄 伟.大黄承气汤联合保留灌肠对重症急性胰腺炎肠道菌群及免疫功能的影响*[J].陕西中医,2020,(10):1418.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.021]
YU Hui,YANG Ting,HUANG Wei..Effect of Dahuang Chengqi decoction combined with retention enema on intestinal flora and immune function in severe acute pancreatitis[J].,2020,(3):1418.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.021]
[4]陈紫薇,陈 明△.从脾论治慢性肾脏病的生物学基础探讨*[J].陕西中医,2020,(11):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
CHEN Ziwei,CHEN Ming..Discuss the biological foundation for chronic disease therapy from treatment through the spleen[J].,2020,(3):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
[5]钟方红,皮特俊章,钟 琴,等.中药对高尿酸血症患者肠道菌群影响的研究进展[J].陕西中医,2021,(2):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]
ZHONG Fanghong,PI Tejunzhang,ZHONG Qin,et al.Research progress of the effect of traditional Chinese medicine on intestinal flora of patients with hyperuricemia[J].,2021,(3):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]
[6]敬秀平,宋小平,刘 珊.加味白头翁汤灌肠治疗慢性溃疡性结肠炎临床研究[J].陕西中医,2021,(8):1060.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.018]
JING Xiuping,SONG Xiaoping,LIU Shan.Study on the therapeutic effect and inflammatory mechanism of enema with modified Baitouweng decoction in the treatment of chronic ulcerative colitis[J].,2021,(3):1060.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.018]
[7]何佳美,银子涵,梁繁荣.基于“心合小肠”理论探讨针灸调控肠道菌群治疗心血管疾病的可行性[J].陕西中医,2021,(11):1581.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.020]
HE Jiamei,YIN Zihan,LIANG Fanrong.Exploration on feasibility of acupuncture and moxibustion preventing cardiovascular diseases by regulation of intestinal flora interaction based on heart and small intestine[J].,2021,(3):1581.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.020]
[8]李慧敏,李鹏辉,吉兰洁,等.连术消渴颗粒对2型糖尿病模型大鼠肠道菌群、肠黏膜屏障功能及水通道蛋白的影响[J].陕西中医,2021,(12):1663.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.002]
LI Huimin,LI Penghui,JI Lanjie,et al.Effect of Lianzhu Xiaoke granule on intestinal flora,intestinal mucosal barrier function and aquaporin in type 2 diabetes model rats[J].,2021,(3):1663.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.002]
[9]宋 丽,石 蕊,赵香君.手足十二针联合加味茵陈蒿汤治疗非酒精性脂肪肝及对患者肠道菌群的影响[J].陕西中医,2022,(2):252.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.027]
SONG Li,SHI Rui,ZHAO Xiangjun.Effect of hand foot twelve needles combined with modified Yinchenhao decoction on intestinal flora of patients with nonalcoholic fatty liver disease[J].,2022,(3):252.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.027]
[10]王士萌,陈 璐,冯晓玲.肾虚血瘀型复发性流产与肠道菌群相关性研究进展[J].陕西中医,2022,(2):261.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.029]
WANG Shimeng,CHEN Lu,FENG Xiaoling.Mechanism correlation and research progress between recurrent spontaneous abortion of kidney deficiency-blood stasis type and intestinal flora[J].,2022,(3):261.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.029]